Pharma IQ Glossary: Drug Discovery
Drug Discovery is defined as the process by which drugs are discovered and/or designed. The process of drug discovery involves the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy. Once a compound has shown its value in these tests, it will begin the process of drug development prior to clinical trials. Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, "expensive, difficult, and inefficient process" with low rate of new therapeutic discovery.
How Sanofi is using AI to accelerate time to market for new drugs
June 06 by Leila Hawkins
Learn more about how AI can accelerate the drug discovery process
AstraZeneca shares positive results for its drug to lower cholesterol
April 13 by Leila Hawkins
Pharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death
Top five countries running the most clinical trials
April 08 by Leila Hawkins
Pharma IQ looks at the five countries conducting the most clinical trials and why sponsors choose them
Future Directions of Compound Management Field Require Further Evolution of Drug Discovery Processes
August 02 by Pharma IQ NewsPHILADELPHIA, PA – Pharma IQ, a division of IQPC, announces the 7th Annual Compound Management & Integrity Summit, being held September 26 to 30, 2011 in Philadelphia. Industry leaders...
Case Study: Early Alliances and Risk Sharing Portfolios: An Academic’s Perspective
January 13 by Pharmaceuticals & Biotechnology EditorAstraZeneca: Discovering Drugs Through Partnerships
October 25 by Pharma IQDrug discovery projects are not cheap. The start of projects to consider new treatments for a range of diseases can be vast in their scope, meaning the development process can cost a significant amoun...
